Psychedelic Deals, Partnerships Skyrocket 500% Since 2019

The push toward mainstream legitimacy is largely what's fueled the rise in dealmaking.

Business deals, partnerships, and mergers in the psychedelics industry have shot up by 500% in the last four years as the sector has gotten hotter and hotter, according to a report from the GlobalData Pharma Intelligence Center Deals Database.

That includes more than 40 business deals done in the sector, Pharmaceutical Today reported, and involve companies that deal in not just psilocybin but also lysergic acid diethylamide (LSD), midomafetamine (MDMA), and other psychedelics.

One such deal highlighted by the report was Clearmind Medicine’s co-development partnership deal with Hebrew University of Jerusalem and Israel-based company SciSparc.

Although there are still no formally approved pharmaceutical psychedelic treatments for medical ailments such as clinical depression, many such treatment regimes are nonetheless in the works and aiming for the green light from the U.S. Food and Drug Administration. That move is required to get widespread production and sales going, Pharmaceutical Today reported.

The push toward mainstream legitimacy is largely what’s fueled the rise in dealmaking, the outlet reported.

The United States is leading the psychedelics sector internationally, with 63 privately held biotech firms involved in R&D regarding psychedelic medical applications. Canada and the United Kingdom were close behind, with 29 and 15 psychedelic firms, respectively.

John Schroyer

John Schroyer has been a reporter since 2006, initially with a focus on politics, and covered the 2012 Colorado campaign to legalize marijuana. He has written about the cannabis industry specifically since 2014, after being on hand for the first-ever legal cannabis sales on New Year’s Day that year in Denver. John has covered subsequent marijuana market launches in California and Illinois, has written about every aspect of the marijuana trade, and was part of the team that built the cannabis industry’s first-ever trade show, MJBizCon. He joined Green Market Report in 2022.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.